Clinical Trial

RISE Versus Advocacy-based Enhanced Care as Usual for Patients Experiencing IPV

Study acronym: RISE
Recruiting
View on ClinicalTrials.gov →
Summary
This study aims to improve treatment for Veterans Health Administration (VHA) patients who experience intimate partner violence (IPV). This study will evaluate two brief counseling interventions for VHA patients who have experienced IPV in the past 12 months: Recovering from IPV through Strength and Empowerment (RISE) and advocacy-based Enhanced Care as Usual (ECAU). The RISE intervention includes up to 8 sessions and includes specific topic areas (e.g., social support, health effects, resources). The other intervention, ECAU, includes a single session that includes supportive education about IPV and health effects, discussion of ways to increase safety, and information about resources. This study will test which approach is better for improving self-efficacy and other aspects of health. Participants will answer surveys about their self-efficacy and other health and safety indicators (e.g., mental health symptoms) right before receiving treatment, approximately 12 weeks later, and then every three months after that for one year. Participation in this research will last about 15 months.
Protocol Amendment History 3 amendments
This ClinicalTrials.gov record has been amended 3 times since 2025-04-01; most recent amendment 2025-10-09.
Status change: Not Yet Recruiting → Recruiting 2025-09-16
Trial Details
NCT Number NCT06906302
Lead Sponsor Boston University
Collaborators: VA Boston Healthcare System, VA Philadelphia Healthcare System, VA Minnesota Healthcare System, Patient-Centered Outcomes Research Institute
Conditions Intimate Partner Violence (IPV)
Enrollment 172 participants
Start Date 2025-09-15
Primary Completion 2030-01 (estimated)
Study Completion 2030-01 (estimated)
Updated on ClinicalTrials.gov 2025-10-14